60 views
Alnylam pioneered RNAi (RNA interference) therapeutics—an innovative class of medicines that silence genes that cause or contribute to disease. We are a fast-growing, global biopharmaceutical company driven to positively impact the lives of people around the world, both through our medicines and through our actions beyond the laboratory. We invite you to learn more at alnylam.com.br CORP-BRA-00035